Key facts
- This page summarizes Michael E. Sneed's Form 4 filing for Kenvue Inc. (KVUE).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Aug 2023, 18:23.
Michael E. Sneed - 23 Aug 2023 Form 4 Insider Report for Kenvue Inc. (KVUE)
- Reporting relationship
- Director
- Issuer ticker
- KVUE
- Reported as of
- 23 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Aug 2023, 18:23:12 UTC
- Prior SEC filing
- 08 May 2023
- Next SEC filing
- 13 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alla Berenshteyn, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael E. Sneed filed Form 4 for Kenvue Inc. (KVUE) on 25 Aug 2023.
Change
- Previous filing in this sequence was filed on 08 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KVUE
transaction
Common Stock
Other
- Transaction value
- Shares
- +10,787
- Change %
- Price
- Shares after
- 10,787
- Date
- 23 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KVUE
transaction
Derivative
Deferred Share Units
Award
- Transaction value
- $0
- Shares
- +7,620
- Change %
- Price
- $0.000000
- Shares after
- 7,620
- Date
- 23 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,620
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.
Footnote F2
Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).